Centhaquin
Product Specifications
UNSPSC Description
Centhaquine (Centhaquin; PMZ-2010) is a novel agent has the potential for treatment of? haemorrhagic shock. Centhaquine (Centhaquin; PMZ-2010) can augment cardiac output, reduce?systemic vascular resistance in haemorrhagic models[1][2].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/centhaquin.html
Purity
99.87
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
CC1=CC=CC(N(CC2)CCN2CCC3=NC4=C(C=CC=C4)C=C3)=C1
Molecular Weight
331.45
References & Citations
[1]Srimal RC,et al. Pharmacological studies on 2-(2-(4-(3-methylphenyl)-1-piperazinyl)ethyl) quinoline (centhaquin). I. Hypotensive activity.Pharmacol Res. 1990 May-Jun;22(3):319-29.|[2]Papalexopoulou K, et al. Centhaquin Effects in a Swine Model of Ventricular Fibrillation: Centhaquin and Cardiac Arrest.Heart Lung Circ. 2017 Aug;26(8):856-863.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-106690/Centhaquin-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-106690/Centhaquin-SDS-MedChemExpress.pdf
Clinical Information
Phase 4
CAS Number
57961-90-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1038343 Inquire
Recombinant Salmonella gallinarum DNA mismatch repair protein MutS (mutS), partial
Ask
View Details 